Editas Archives -

CRISPR Therapeutics is to receive a hefty $900m payment from Vertex after the companies amended a collaboration to

Nobel winner Charpentier’s CRISPR Therapeutics gets $900m in reworked Vertex deal

https://pharmaphorum.com/news/nobel-winner-charpentiers-crispr-therapeutics-gets-900m-in-reworked-vertex-deal/

A first patient has been treated in a trial of an Allergan and Editas drug based on CRISPR/Cas9,

First patient dosed in trial of Allergan/Editas’ CRISPR blindness drug

https://pharmaphorum.com/news/first-patient-dosed-in-trial-of-allergan-editas-crispr-blindness-drug/

Shares in firms developing therapies based on CRISPR gene editing technology have fallen after the resignation of the

CRISPR gene editing stocks fall after Editas CEO resigns

https://pharmaphorum.com/news/crispr-gene-editing-stocks-fall-after-editas-ceo-resigns/

Editas